PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS. Electronic address: mushtaqmu@gmail.com.\', \'Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S2666-6367(21)01067-810.1016/j.jtct.2021.07.005
?:hasPublicationType
?:journal
  • Transplantation and cellular therapy
is ?:pmid of
?:pmid
?:pmid
  • 34256172
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all